2014 ATA therapy guidelines: 5. Research

This post continues my series of paraphrases of Jonklaas et al's 2014 guidelines that I left unfinished weeks ago. Here I provide paraphrases and quotations of what they set forth for the "ethics" of research in thyroid therapy in Section 18, and what they recommend as topics for future research in thyroid therapy. I provide …

Continue reading 2014 ATA therapy guidelines: 5. Research

2014 ATA Therapy guidelines: 4. Using Synthetic T3

This post continues my paraphrase of Jonklaas et al's 2014 "Guidelines for the Treatment of Hypothyroidism: Prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement." As I've explained in my previous post, I've decided not to let my summaries of ATA statements be an uninterrupted series of self-justifications and defenses. I've decided …

Continue reading 2014 ATA Therapy guidelines: 4. Using Synthetic T3

2014 ATA Therapy guidelines: 3. Desiccated thyroid

If we want to disagree with the American Thyroid Association's prejudice against animal sources of thyroid hormone, we should to at least prove we're trying to listen to them. Then we should fairly point out what they didn't say, what truths they would rather not admit, and where they are being unfair or inconsistent. This post …

Continue reading 2014 ATA Therapy guidelines: 3. Desiccated thyroid

2014 ATA Thyroid therapy guidelines: 2. Ethics

Here I move on to part 2 of my summary of ATA thyroid therapy guidelines, where they try to defend the ethics their own stance (Jonklaas et al, 2014). Their self-righteous, defensive and arrogant reply to question 11 deserves its own post. ("WE" = Endocrinologists and other doctors who treat hypothyroidism. Anything in quotation marks is directly …

Continue reading 2014 ATA Thyroid therapy guidelines: 2. Ethics

2014 ATA thyroid therapy guidelines: 1. Levothyroxine

In this series of posts, I paraphrase a 2014 thyroid therapy guidelines document in a way that even the brain-fogged hypothyroid patient can understand more quickly and easily than reading the original version. MY SUMMARY'S AIMS AND METHODS Every thyroid patient understand the basics about what is being said about their therapy by the American …

Continue reading 2014 ATA thyroid therapy guidelines: 1. Levothyroxine

Pharmaceutical prejudice can lead to a thyroid therapy dystopia

I really DON'T want to be gloomy all the time. I DO believe there is hope for positive change in thyroid therapy today. But now and then we have to consider "what is the worst that could happen?" I want to show you where we are now, where we could all be headed if we …

Continue reading Pharmaceutical prejudice can lead to a thyroid therapy dystopia

Thyroid pharmaceutical prejudice: How it works

By Tania S. Smith.  Updated May 8, 2019 "Thyroid pharmaceutical prejudice" is simply a bias against one thyroid hormone pharmaceutical type in favor of another. Prejudice claims that a particular thyroid medication is intrinsically unsafe or ineffective, for all patients under almost all circumstances.  It's a type of "sweeping generalization" fallacy. The main aim of …

Continue reading Thyroid pharmaceutical prejudice: How it works